caprylates has been researched along with glucagon-like peptide 1 (7-36)amide in 1 studies
| Studies (caprylates) | Trials (caprylates) | Recent Studies (post-2010) (caprylates) | Studies (glucagon-like peptide 1 (7-36)amide) | Trials (glucagon-like peptide 1 (7-36)amide) | Recent Studies (post-2010) (glucagon-like peptide 1 (7-36)amide) |
|---|---|---|---|---|---|
| 5,061 | 100 | 2,339 | 404 | 54 | 38 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beglinger, C; Castelli, MC; Drewe, J; Friedman, K; Huber, AR; Poller, B; Steinert, RE | 1 |
1 trial(s) available for caprylates and glucagon-like peptide 1 (7-36)amide
| Article | Year |
|---|---|
Orally administered glucagon-like peptide-1 affects glucose homeostasis following an oral glucose tolerance test in healthy male subjects.
Topics: Administration, Oral; Adult; Appetite; Blood Glucose; Caprylates; Cross-Over Studies; Double-Blind Method; Drug Carriers; Gastric Emptying; Glucagon; Glucagon-Like Peptide 1; Glucose Tolerance Test; Homeostasis; Human Growth Hormone; Humans; Incretins; Insulin; Intestinal Absorption; Male; Peptide Fragments; Postprandial Period; Reference Values; Young Adult | 2009 |